Mochi alternatives: narrow the comparison first

A broad menu creates several different alternatives

Mochi lists approved and compounded treatments across multiple formulations. The relevant alternative depends on which path a clinician proposes. Choose a comparison based on the actual medicine and the service you need; a generic cheapest-provider list can hide a change in product status or supply period.

Ro: for a branded-access comparison

Ro’s reviewed offering lists approved products with separate care and medication costs. Its $149 ongoing monthly care fee is higher than Mochi’s advertised $79 membership, but those figures do not settle the pharmacy bill, diagnostic charges or the service value. Get matched medication quotes and clarify insurance responsibilities before concluding that either total is lower.

Ivim: compare bundle timing, not only averages

Ivim publishes a $75 monthly care fee and separate medication bundles. That is a different payment question from a monthly medication refill. Ask for the amount due immediately and what follows the bundle period, then compare that schedule with Mochi’s written terms. Confirm how clinical follow-up continues if a medication purchase and membership renew at different times.

CoreAge: simpler-looking fees, unresolved total

CoreAge advertises compounded semaglutide without a separate membership fee. Its public $79 and $99 displays conflict, so neither should be treated as your confirmed renewal bill. Ask for the exact supplied quantity, preparation and recurring charge. This narrower offer is relevant only to the appropriate product-specific discussion, not every pathway on Mochi’s menu.

Compare the services you would actually use

Ask each provider who handles nutrition or other support if it is part of your reason for joining, what clinician access includes and whether additional appointments cost extra. A lower care fee can be poor value if essential services fall outside it. We have not tested the providers as patients and cannot rank clinical quality or response speed.

Sources and comparison limits

We use public information, have not enrolled as patients and do not measure clinical quality or support speed. Individual eligibility, state access, prescription and current terms must be confirmed directly.

• Mochi Health: official service information · Our review
• Ro: official service information · Our review
• Ivim Health: official service information · Our review
• CoreAge Rx: official service information · Our review
• FDA: concerns with unapproved GLP-1 drugs ↗

Compounded drugs are not FDA-approved. This comparison is not a treatment recommendation. See our commercial disclosure and comparison method.